K-numberK251683
Device nameDeseyne (vifilcon C) Daily Disposable Soft (hydrophilic) Contact Lens with UV Blocking for Presbyopia (EDOF)
ApplicantBruno Vision Care, LLC
Product codeLPL
Device classClass II
Decision dateDec 23, 2025
DecisionSubstantially Equivalent
Regulation886.5925
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

Deseyne (vifilcon C) is a daily disposable soft contact lens made of hydrophilic material designed to correct refractive errors (myopia and hyperopia) in presbyopic patients. The lens includes an Extended Depth of Focus (EDOF) feature with a central 1.0 mm dome-shaped zone to mitigate presbyopia effects, and it contains UV-blocking components and hyaluronic acid in the packaging solution.

Technological characteristics

The subject device differs from the predicate device (K240918) by adding a presbyopic lens design with a 0.5 mm central zone radius and 8.0D power difference; the predicate has no central zone. Both use the same vifilcon C material, 60% water content, 1.403 refractive index, and 27.5×10⁻¹¹ oxygen permeability. The subject device center thickness is 0.07 mm versus 0.05 mm for the predicate.

Test standards cited

ISO 18369-2:2006 (tolerances), ISO 18369-3:2006 (measurement methods), and ISO 18369-4:2006 (physicochemical properties). Biocompatibility testing was not required per FDA's 2023 Biocompatibility Guidance referencing ISO 10993-1.

Substantial equivalence argument

Both devices are daily disposable soft contact lenses made of vifilcon C with identical material properties, water content, and refractive index, and both correct myopia and hyperopia in the same FDA classification group (Group IV, high water, ionic). The principal difference—the presbyopic EDOF design—does not raise different safety or effectiveness questions, and clinical testing demonstrated statistically significant improvement in depth of focus (0.78D increase) with no adverse events reported.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →